Name | Ruzotolimod |
---|
Description | Ruzotolimod is the agonist of TLR7. Ruzotolimod has the potential for the research of HBV, COVID-19 or SARS-CoV-2 infection (extracted from patent WO2021130195A1)[1]. |
---|---|
Related Catalog | |
Target |
TLR7[1] |
References |
[1]. Qingyan BO, et al. Method of treating virus infection using a tlr7 agonist. Patent WO2021130195A1. |
Molecular Formula | C14H18N4O5S |
---|---|
Molecular Weight | 354.38 |